Patient-specific induced pluripotent stem cell properties implicate Ca2+-homeostasis in clinical arrhythmia associated with combined heterozygous RYR2 and SCN10A variants
PMID: 37122207
Gene: TNNT2
HGNC ID: 11949
Patient-specific induced pluripotent stem cell properties implicate Ca2+-homeostasis in clinical arrhythmia associated with combined heterozygous RYR2 and SCN10A variants
PMID: 37122207
Gene: TNNT2
HGNC ID: 11949
The proband, a four-month-old boy, presented with polymorphic ventricular tachycardia.
Case#: 4 month old boy
DiseaseAssertion: Polymorphic ventricular tachycardia
FamilyInfo: His father carried the RYR2 variant and had ventricular premature beats. His mother carried the SCN10A variant and was asymptomatic.
ParentalTesting: Yes. Familial genetic testing showed the RYR2-A1855D variant was inherited from the father and the SCN10A-Q1362H variant was inherited from the mother.
CasePresentingHPOs: HP:0004756
CaseHPOFreeText: 4-month-old male presenting with polymorphic ventricular tachycardia.
CaseNotHPOs: not reported
CaseNotHPOFreeText: not reported
CasePreviousTesting: Clinical cardiac evaluation followed by genetic testing
Genotyping Method: Genetic testing identified novel heterozygous RYR2-A1855D and SCN10A-Q1362H variants.
FunctionalAnalysis: Functional studies showed abnormal calcium handling, prolonged action potentials, increased susceptibility to early afterdepolarizations, and disrupted Ca2+ homeostasis in cells carrying both variants.
Variant: RYR2 (heterozygous) SCN10A
ClinVar: not found
CAID: not found
gnomAD: not found
AdditionalInfo: